Loading...
Rising Regulation And Cost Burdens Will Strain US Healthcare Margins
AnalystLowTarget's Fair Value
US$55.00
1.5% overvalued intrinsic discount06 Sep
US$55.83
1Y
493.2%7D
-11.7%1Y
493.2%7D
-11.7%You can edit this narrative until Sep 6 10:12 PM. Then, changes will post as Updates.